Biotech and medical business blog

Visit BioHealth Investor

Is Lillys Loss Really Others Gain? (LLY, PFE, BMY, SNE)

Posted on June 24, 2008

Eli Lilly & Co. (NYSE: LLY) is following the lead of Pfizer . in need of a new breed of drugs, and with shares on the 52-week low list and on a multi-year low list.The FDA has pushed back a decision regarding its anti-clotting blood thinner with its partner Daiichi Sankyo in Japan. Prasugrel is called [...]...

Original article link